mianserin (Tolvon) Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Mianserin, sold under the brand name Tolvon among others, is an atypical antidepressant that is used primarily in the treatment of depression in Europe and elsewhere in the world. It is a tetracyclic antidepressant (TeCA). Mianserin is closely related to mirtazapine, both chemically and in terms of its actions and effects, although there are significant differences between the two drugs.   Wikipedia

Chemistry

More Chemistry

Pharmacology

Drug Pricing (per unit)

Australia

$0.1209 - $0.2551
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

1,2,3,4,10,14b-hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine | bolvidon | mianserin | (+/-)-mianserin | mianserina | mianserine | mianserine hcl | mianserine hydrochloride | mianserin hcl | mianserin hydrochloride | mianserinum | mianseryna | norval | org gb 94

Organizations (5)

Research & Development (5)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (7)

Approved Indications (1)


 

Depression

Experimental Indications - Clinical Trial Phases 1-4 (7)


 

Anxiety Disorders (Phase 3)

Dementia (Phase 3)

Depression (Phase 4)

Depressive Disorder ()

Psychophysiologic Disorders (Phase 3)

Schizophrenia (Phase 3)

Stress Disorders, Post-Traumatic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial Organizations: 5

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue